BRPI0720689A2 - Vacina de célula tumoral universal para utilização profilática e terapêutica anticâncer - Google Patents

Vacina de célula tumoral universal para utilização profilática e terapêutica anticâncer

Info

Publication number
BRPI0720689A2
BRPI0720689A2 BRPI0720689-5A2A BRPI0720689A BRPI0720689A2 BR PI0720689 A2 BRPI0720689 A2 BR PI0720689A2 BR PI0720689 A BRPI0720689 A BR PI0720689A BR PI0720689 A2 BRPI0720689 A2 BR PI0720689A2
Authority
BR
Brazil
Prior art keywords
antichange
prophylatic
tumor cell
therapeutic use
cell vaccine
Prior art date
Application number
BRPI0720689-5A2A
Other languages
English (en)
Inventor
Habib Fakhrai
Daniel L Shawler
Original Assignee
Novarx
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novarx filed Critical Novarx
Publication of BRPI0720689A2 publication Critical patent/BRPI0720689A2/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5152—Tumor cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5156—Animal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55522—Cytokines; Lymphokines; Interferons
    • A61K2039/55527—Interleukins
    • A61K2039/55533—IL-2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/80—Vaccine for a specifically defined cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oncology (AREA)
  • Zoology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
BRPI0720689-5A2A 2006-12-20 2007-12-20 Vacina de célula tumoral universal para utilização profilática e terapêutica anticâncer BRPI0720689A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US87622206P 2006-12-20 2006-12-20
PCT/US2007/088457 WO2008105978A1 (en) 2006-12-20 2007-12-20 Universal tumor cell vaccine for anti cancer therapeutic and prophylactic utilization

Publications (1)

Publication Number Publication Date
BRPI0720689A2 true BRPI0720689A2 (pt) 2014-02-25

Family

ID=39233098

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0720689-5A2A BRPI0720689A2 (pt) 2006-12-20 2007-12-20 Vacina de célula tumoral universal para utilização profilática e terapêutica anticâncer

Country Status (15)

Country Link
US (2) US8293252B2 (pt)
EP (2) EP2101812A1 (pt)
JP (2) JP2010514697A (pt)
KR (1) KR20090107507A (pt)
AU (1) AU2007347689B2 (pt)
BR (1) BRPI0720689A2 (pt)
CA (1) CA2673607A1 (pt)
EA (1) EA017613B1 (pt)
ES (1) ES2547958T3 (pt)
HU (1) HUE027617T2 (pt)
MX (1) MX2009006691A (pt)
NO (1) NO20092339L (pt)
NZ (1) NZ578181A (pt)
SG (1) SG192304A1 (pt)
WO (1) WO2008105978A1 (pt)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2342334A4 (en) * 2008-09-29 2012-03-14 Univ Pennsylvania VACCINES DIRECTED TO TUMOR VESSEL MARKERS
US20130225659A1 (en) * 2010-07-19 2013-08-29 Isis Pharmaceuticals, Inc. Modulation of nuclear-retained rna
WO2012156969A1 (en) 2011-05-17 2012-11-22 Hadasit Medical Research Services And Development Ltd. Allogeneic tumor cell vaccination
US20130095575A1 (en) * 2011-10-03 2013-04-18 The Board Of Trustees Of The Leland Stanford Junior University Methods for Fractionation, Analysis and Collection of Microvesicles From Patient Samples
TW201536329A (zh) 2013-08-09 2015-10-01 Isis Pharmaceuticals Inc 用於調節失養性肌強直蛋白質激酶(dmpk)表現之化合物及方法
AU2018214979A1 (en) * 2017-02-01 2019-08-15 Acceleron Pharma Inc. TGFβ and actrii antagonists for use in increasing immune activity
EP3999112A4 (en) * 2019-07-19 2023-08-23 Dana-Farber Cancer Institute, Inc. TUMOR VACCINE COMPOSITIONS AND METHODS OF USE THEREOF FOR THE PREVENTION AND/OR TREATMENT OF CANCER
JP2023504659A (ja) * 2019-12-03 2023-02-06 ニューボーゲン，インコーポレイティド 腫瘍細胞ワクチン
CN111351942B (zh) * 2020-02-25 2024-03-26 北京尚医康华健康管理有限公司 肺癌肿瘤标志物筛选系统及肺癌风险分析系统
AU2021368780A1 (en) * 2020-11-02 2023-06-22 Neuvogen, Inc. Tumor cell vaccines
EP4396352A4 (en) 2021-09-01 2025-10-01 Ionis Pharmaceuticals Inc COMPOUNDS AND METHODS FOR REDUCING DMPK EXPRESSION

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5772995A (en) 1994-07-18 1998-06-30 Sidney Kimmel Cancer Center Compositions and methods for enhanced tumor cell immunity in vivo
AU2001231204A1 (en) * 2000-01-27 2001-08-07 Sidney Kimmel Cancer Center Genetically engineered tumor cell vaccines
ES2373431T3 (es) * 2000-03-31 2012-02-03 Novarx Células genéticamente modificadas que expresan un inhibidor de tgf-beta, siendo las células células de cáncer de pulmón.
US6984522B2 (en) * 2000-08-03 2006-01-10 Regents Of The University Of Michigan Isolation and use of solid tumor stem cells
GB0406215D0 (en) * 2004-03-19 2004-04-21 Procure Therapeutics Ltd Prostate stem cell

Also Published As

Publication number Publication date
US8293252B2 (en) 2012-10-23
WO2008105978A1 (en) 2008-09-04
EA017613B1 (ru) 2013-01-30
EA200970607A1 (ru) 2010-04-30
AU2007347689A1 (en) 2008-09-04
MX2009006691A (es) 2009-09-09
US20130064856A1 (en) 2013-03-14
CA2673607A1 (en) 2008-09-04
HUE027617T2 (en) 2016-11-28
SG192304A1 (en) 2013-08-30
EP2101812A1 (en) 2009-09-23
NO20092339L (no) 2009-08-25
ES2547958T3 (es) 2015-10-09
AU2007347689A2 (en) 2009-07-30
JP2013129677A (ja) 2013-07-04
AU2007347689B2 (en) 2013-08-15
EP2404614A1 (en) 2012-01-11
NZ578181A (en) 2012-02-24
EP2404614B1 (en) 2015-06-17
US20100047289A1 (en) 2010-02-25
JP2010514697A (ja) 2010-05-06
KR20090107507A (ko) 2009-10-13

Similar Documents

Publication Publication Date Title
BRPI0720689A2 (pt) Vacina de célula tumoral universal para utilização profilática e terapêutica anticâncer
PT2433954E (pt) Identificação de antigénios associados a tumores para diagnóstico e terapia
BRPI0921321A2 (pt) métodos para o tratamento de indwcções e tumores
BRPI0819630A2 (pt) Montagem de interface de paciente para terapia respiratória
BRPI0822655A2 (pt) Implemento e sistema para cuidado oral
HUE037082T2 (hu) Új lipidek és készítmények terápiás hatóanyagok szállítására
BRPI0907257A2 (pt) Sistema e métodos para estimulação elétrica terapêutica
HUE037105T2 (hu) Eljárások és készítmények tumorok megsemmisítésére
BRPI0717638A2 (pt) Anticorpors e imunoconjugados e usos para os mesmos
BRPI1013432A2 (pt) derivado de indolizina e uso do mesmo para propósitos médicos
BRPI0820556A2 (pt) Bactéria e métodos para uso das mesmas
PT2868315T (pt) Formulações melhoradas e métodos para liofilização e liofilizados assim produzidos
BRPI0817299A2 (pt) Vacinas e componentes de vacina para inibição de células microbianas
BRPI0807544A2 (pt) Sólido farmacêutico e dose de vacina
BRPI1016234A2 (pt) dispositivo aplicador para uso médico e/ou cosmético.
BRPI1009847A2 (pt) conectores médicos e métodos de uso
PL2535716T3 (pl) Marker nowotworowy i cel terapeutyczny
BRPI0912768A2 (pt) vacinas de poliproteínas recombinante para o tratamento e diagnóstico de leishmaniose
BRPI0812264A2 (pt) Vesícula, e, preparação externa para pele
BRPI1006733A2 (pt) kit para formação de imagem médica marcada e/ou produtos terapêuticos, agente de pré-marcação, sonda de formação de imagem, sonda terapêutica e método
FI20075881A0 (fi) Lääketieteellinen väline ja sen käyttö
BRPI0919236A2 (pt) terapêutica e vacinas de combinação de gas
BRPI0822349A2 (pt) composições e métodos para tratar doenças lisossômicas
BRPI0921087A2 (pt) válvula para utilização universal e diversas finalidades
BRPI0819488A2 (pt) Dispositivos de terapia e gel térmico

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B08F Application dismissed because of non-payment of annual fees [chapter 8.6 patent gazette]
B08K Patent lapsed as no evidence of payment of the annual fee has been furnished to inpi [chapter 8.11 patent gazette]